Mariette, X; Fisher, B; Papas, A; Grader-Beck, T; Bootsma, H; Ng, WF; Daele, PLV; Finzel, S; Elgueta, S; Hermann, J; Mccoy, SS; Bookman, A; Sopala, M; Hua, E; Chen, L; Scheurer, C; Hueber, W.
SAFETY AND EFFICACY OF ISCALIMAB IN PATIENTS WITH SJÖGREN'S DISEASE: 48-WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL
ANN RHEUM DIS. 2024; 83:
Doi: 10.1136/annrheumdis-2024-eular.3024
Web of Science
FullText
FullText_MUG